Market research
SCU.AU Stemcell United Limited
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Community
Investor discussion
1 comment
Sign in to join the SCU.AU discussion.
5 years, 5 months ago
Stemcell United Limited is currently in a long term downtrend where the price is trading 12.7% below its 200 day moving average.
From a valuation standpoint, the stock is 92.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 19.3.
Stemcell United Limited's total revenue rose by 411.6% to $4M since the same quarter in the previous year.
Its net income has dropped by 64.9% to $-1M since the same quarter in the previous year.
Finally, its free cash flow fell by 68.9% to $-535K since the same quarter in the previous year.
Based on the above factors, Stemcell United Limited gets an overall score of 2/5.